MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/archinternmed.2012.3310

Медицинская библиотека · Archives of internal medicine · 2012

The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries.

Damasceno Albertino, Mayosi Bongani M, Sani Mahmoud, Ogah Okechukwu S, Mondo Charles, Ojji Dike, Dzudie Anastase, Kouam Charles Kouam, Suliman Ahmed, Schrueder Neshaad, Yonga Gerald, Ba Serigne Abdou, Maru Fikru, Alemayehu Bekele, Edwards Christopher, Davison Beth A, Cotter Gad, Sliwa Karen

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Acute heart failure (AHF) in sub-Saharan Africa has not been well characterized. Therefore, we sought to describe the characteristics, treatment, and outcomes of patients admitted with AHF in sub-Saharan Africa.

METHODS

The Sub-Saharan Africa Survey of Heart Failure (THESUS-HF) was a prospective, multicenter, observational survey of patients with AHF admitted to 12 university hospitals in 9 countries. Among patients presenting with AHF, we determined the causes, treatment, and outcomes during 6 months of follow-up.

RESULTS

From July 1, 2007, to June 30, 2010, we enrolled 1006 patients presenting with AHF. Mean (SD) age was 52.3 (18.3) years, 511 (50.8%) were women, and the predominant race was black African (984 of 999 [98.5%]). Mean (SD) left ventricular ejection fraction was 39.5% (16.5%). Heart failure was most commonly due to hypertension (n = 453 [45.4%]) and rheumatic heart disease (n = 143 [14.3%]). Ischemic heart disease (n = 77 [7.7%]) was not a common cause of AHF. Concurrent renal dysfunction (estimated glomerular filtration rate, <30 mL/min/173 m(2)), diabetes mellitus, anemia (hemoglobin level, <10 g/dL), and atrial fibrillation were found in 73 (7.7%), 114 (11.4%), 147 (15.2%), and 184 cases (18.3%), respectively; 65 of 500 patients undergoing testing (13.0%) were seropositive for the human immunodeficiency virus. The median hospital stay was 7 days (interquartile range, 5-10), with an in-hospital mortality of 4.2%. Estimated 180-day mortality was 17.8% (95% CI, 15.4%-20.6%). Most patients were treated with renin-angiotensin system blockers but not β-blockers at discharge. Hydralazine hydrochloride and nitrates were rarely used.

CONCLUSIONS

In African patients, AHF has a predominantly nonischemic cause, most commonly hypertension. The condition occurs in middle-aged adults, equally in men and women, and is associated with high mortality. The outcome is similar to that observed in non-African AHF registries, suggesting that AHF has a dire prognosis globally, regardless of the cause.

Для цитирования: Damasceno Albertino, Mayosi Bongani M, Sani Mahmoud, Ogah Okechukwu S, Mondo Charles, Ojji Dike, Dzudie Anastase, Kouam Charles Kouam, Suliman Ahmed, Schrueder Neshaad, Yonga Gerald, Ba Serigne Abdou, Maru Fikru, Alemayehu Bekele, Edwards Christopher, Davison Beth A, Cotter Gad, Sliwa Karen. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries.. Archives of internal medicine. 2012. DOI: 10.1001/archinternmed.2012.3310.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.